NY-MHW-LTD
16.11.2021 16:02:11 CET | Business Wire | Press release
MHW, Ltd., the leading service provider for wine, spirits, beer and cider in the United States, has announce the successful acquisition of two nationally licensed importation companies, USA Wine West and USA Wine Imports, each of whom have decades of experience in fine wine distribution, logistics management, market strategy, compliance and administration.
“Over the last 25 years, USA Wine West has provided unparalleled logistics, compliance and administrative import services to foreign and domestic wineries who launch in the U.S.,” says Founder Steve Melchiskey, who will continue leading the USA Wine West team and join MHW as Vice President of Sales and Development. “Becoming a part of MHW enables us to carry on that mission with greater resources and capabilities. This is especially exciting for the passionate wineries and individuals we work with, as well as our world-class team who has been critical to this success.”
MHW, USA Wine West and USA Wine Imports will continue to service their respective client portfolios while they explore additional ways to deliver value through their partnership with clients over time by expanding on service capabilities, such as global consolidated logistics and more comprehensive direct-to-retail offerings.
“MHW is thrilled to welcome USA Wine West and USA Wine Imports to our team,” says MHW Chief Executive Officer Gabe Barkley. “Both companies enhance our leadership in serving the needs of the global fine wine market across all segments. We share a common DNA of building and valuing lasting client relationships. That orientation toward partnership is vital to our ongoing success. Because my career began in fine wine retail, I am personally thrilled about our expanded ability to help wine producers – from family-owned wineries to private-label programs – establish their presence in the U.S. market alongside our existing leadership positions in spirits and malt beverages.”
“It has been gratifying and humbling to have presided over a period of incredible growth at USA Wine Imports and we are very excited to be passing the baton to such a capable partner in MHW,” says former USA Wine Imports Vice President Nicolas Mestre. “This partnership will allow our portfolios the additional resources they require to scale and thrive in the market.” Sandi Bartel, USA Wine’s longtime General Manager, will continue to manage day-to-day operations.
About MHW, LTD.
MHW, LTD . is the leading beverage alcohol service partner in the United States, European Union and United Kingdom, specializing in strategic, scalable back-office solutions including compliance management, licensing, operations, logistics, fulfillment, accounting, business insight reporting, and technology. Since 1995, MHW has served as the national importer and distributor to international brands of all sizes, helping more than 100,000 wine, spirits and beer products successfully enter the U.S. MHW’s global wholesale capabilities give clients access to the retail trade in four key U.S. markets, the EU and UK. Companies who partner with MHW have the competitive advantage to focus time and effort on building brand sales. With strategic and attentive teams who have decades of back-office beverage alcohol experience, MHW offers unparalleled expertise and service excellence. To learn how to make your mark in the US and EU, please visit mhwltd.com .
About USA Wine West
USA Wine West is a premier provider of national wine import services in the U.S. A fully licensed federal importer, they work in partnership with the sales and marketing teams of foreign and domestic wineries to distribute wine to wholesalers in all 50 states. They work strategically with client portfolios to provide a cost-effective, integrated sales platform, along with an efficient logistical and compliance system designed to support foreign wineries to succeed in this competitive market.
About USA Wine Imports
USA Wine Imports is a national importer of wine and spirits providing wholesale customers distribution in all major wine markets in the U.S. USA Wine Imports works closely with wine and spirits producers, importers, brokers and agents to develop innovative sales and marketing strategies and meet ambitious sales goals in a crowded marketplace. In addition, they handle import, freight, compliance, licensing, warehousing, order fulfillment, invoicing, inventory control and accounting services.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211116005452/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
